| Primary |
| Drug Use For Unknown Indication |
26.3% |
| Pneumonia |
10.3% |
| Helicobacter Infection |
9.7% |
| Product Used For Unknown Indication |
8.5% |
| Nasopharyngitis |
5.5% |
| Upper Respiratory Tract Inflammation |
5.1% |
| Bronchitis |
3.5% |
| Angina Pectoris |
3.4% |
| Gastric Ulcer |
3.4% |
| Hypertension |
3.4% |
| Atypical Mycobacterial Infection |
2.5% |
| Cardiac Failure |
2.5% |
| Gastritis |
2.5% |
| Helicobacter Gastritis |
2.3% |
| Pyrexia |
2.0% |
| Respiratory Tract Infection |
2.0% |
| Acute Tonsillitis |
1.8% |
| Atrial Fibrillation |
1.8% |
| Reflux Oesophagitis |
1.8% |
| Bronchopneumonia |
1.5% |
|
| Erythema Multiforme |
8.7% |
| Liver Disorder |
7.6% |
| Stevens-johnson Syndrome |
7.6% |
| Vomiting |
7.6% |
| Loss Of Consciousness |
5.4% |
| Malaise |
5.4% |
| Tremor |
5.4% |
| Vertigo |
5.4% |
| Jaundice |
4.3% |
| Pneumonia |
4.3% |
| Renal Infarct |
4.3% |
| Rhabdomyolysis |
4.3% |
| Shock |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| White Blood Cell Count Increased |
4.3% |
| Bacteraemia |
3.3% |
| Drug Eruption |
3.3% |
| Enterocolitis Haemorrhagic |
3.3% |
| Face Oedema |
3.3% |
| Hepatitis |
3.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.8% |
| Bronchitis |
9.9% |
| Pyrexia |
9.3% |
| Product Used For Unknown Indication |
7.3% |
| Upper Respiratory Tract Inflammation |
6.0% |
| Pharyngeal Erythema |
5.3% |
| Cough |
4.0% |
| Nasopharyngitis |
3.3% |
| Prophylaxis |
3.3% |
| Antibiotic Prophylaxis |
2.6% |
| Hyperlipidaemia |
2.6% |
| Viral Infection |
2.6% |
| Allergic Bronchitis |
2.0% |
| Hypertension |
2.0% |
| Mycoplasma Infection |
2.0% |
| Respiratory Tract Infection |
2.0% |
| Systemic Inflammatory Response Syndrome |
2.0% |
| Antipyresis |
1.3% |
| Bacterial Infection |
1.3% |
| Escherichia Infection |
1.3% |
|
| Erythema Multiforme |
16.7% |
| Vomiting |
16.7% |
| Loss Of Consciousness |
12.5% |
| Tremor |
12.5% |
| White Blood Cell Count Increased |
12.5% |
| Uveitis |
8.3% |
| White Blood Cell Count Decreased |
8.3% |
| Myalgia |
4.2% |
| Oedema |
4.2% |
| Weight Decreased |
4.2% |
|
| Interacting |
| Crohn's Disease |
25.0% |
| Product Used For Unknown Indication |
16.7% |
| Analgesic Therapy |
8.3% |
| Anxiety |
8.3% |
| Gastritis |
8.3% |
| Lower Respiratory Tract Infection |
8.3% |
| Pain |
8.3% |
| Pain Management |
8.3% |
| Upper Respiratory Tract Infection |
8.3% |
|
| White Blood Cell Count Increased |
100.0% |
|
